Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8898 |
High Similarity |
NPD5283 |
Phase 1 |
0.8837 |
High Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8837 |
High Similarity |
NPD3620 |
Phase 2 |
0.8729 |
High Similarity |
NPD228 |
Approved |
0.8559 |
High Similarity |
NPD3022 |
Approved |
0.8559 |
High Similarity |
NPD3021 |
Approved |
0.8462 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8425 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8425 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.8271 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7985 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7985 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7985 |
Intermediate Similarity |
NPD5109 |
Approved |
0.797 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7941 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7895 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7868 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7868 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4626 |
Approved |
0.781 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7803 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7797 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7752 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7727 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7724 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7717 |
Intermediate Similarity |
NPD7157 |
Approved |
0.771 |
Intermediate Similarity |
NPD3092 |
Approved |
0.771 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7676 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7664 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7647 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7647 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7626 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7622 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7615 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7612 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7609 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7594 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7594 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7594 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7591 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7591 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7591 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7576 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7574 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7569 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7557 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7556 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7552 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7542 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7542 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7533 |
Intermediate Similarity |
NPD37 |
Approved |
0.752 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7519 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7519 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7519 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7519 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6353 |
Approved |
0.75 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7481 |
Intermediate Similarity |
NPD5691 |
Approved |
0.748 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7463 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7458 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7458 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7458 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7451 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7444 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7442 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7431 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7426 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7424 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7424 |
Intermediate Similarity |
NPD3095 |
Discontinued |
0.7424 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7424 |
Intermediate Similarity |
NPD4059 |
Approved |
0.7424 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7424 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7424 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7413 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7413 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7407 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD27 |
Approved |
0.7389 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7386 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7386 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7379 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD9494 |
Approved |
0.736 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7357 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7348 |
Intermediate Similarity |
NPD4093 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7344 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7343 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7338 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD709 |
Approved |
0.7305 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD7228 |
Approved |
0.728 |
Intermediate Similarity |
NPD968 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7252 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2808 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7215 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7214 |
Intermediate Similarity |
NPD2028 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7203 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7203 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD4162 |
Approved |
0.719 |
Intermediate Similarity |
NPD288 |
Approved |
0.719 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7185 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD4584 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7167 |
Intermediate Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.7164 |
Intermediate Similarity |
NPD2286 |
Discontinued |
0.7163 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7154 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7154 |
Intermediate Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7152 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7134 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD3109 |
Approved |
0.7113 |
Intermediate Similarity |
NPD3110 |
Approved |
0.7113 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7109 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD844 |
Approved |
0.7103 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD1039 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7087 |
Intermediate Similarity |
NPD290 |
Approved |
0.7075 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7075 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2898 |
Approved |
0.7047 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7045 |
Intermediate Similarity |
NPD6387 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7042 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7042 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD1751 |
Approved |
0.7034 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7034 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7032 |
Intermediate Similarity |
NPD2977 |
Approved |
0.703 |
Intermediate Similarity |
NPD7310 |
Approved |
0.703 |
Intermediate Similarity |
NPD7311 |
Approved |
0.703 |
Intermediate Similarity |
NPD7312 |
Approved |
0.703 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7029 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7027
|
Intermediate Similarity |
NPD4628 |
Phase 3 |